Overview
Ovagen is described as an ultra-short regulatory peptide capable of modulating gene expression and cellular programs in epithelial and parenchymal tissues. Research suggests hepatoprotective peptides may help support hepatocyte resilience and redox balance in preclinical systems.
Quick Start Summary
– Reconstitution: Add 3.0 mL bacteriostatic water to create ~6.67 mg/mL concentration
– Dosing Range: 800–2000 mcg once daily via subcutaneous injection
– Measurement: At 6.67 mg/mL, 1 unit on U-100 insulin syringe ≈ 66.7 mcg
– Storage (Lyophilized): −20 °C (−4 °F) in dry, dark conditions
– Storage (Reconstituted): 2–8 °C (35.6–46.4 °F); avoid freeze-thaw cycles
Dosing Protocol
Standard Gradual Approach (3 mL Dilution)
| Week | Daily Dose | Units (per injection) |
|---|---|---|
| 1–2 | 800 mcg | 12 units (0.12 mL) |
| 3–4 | 1200 mcg | 18 units (0.18 mL) |
| 5–6 | 1600 mcg | 24 units (0.24 mL) |
| 7–12 | 2000 mcg | 30 units (0.30 mL) |
Route & Frequency: Once daily subcutaneous injection with gradual titration over 8–12 weeks (extendable to 16 weeks).
Reconstitution Steps
1. Draw 3.0 mL bacteriostatic water with sterile syringe
2. Inject slowly down vial wall; avoid foaming
3. Gently swirl/roll until dissolved (do not shake)
4. Label and refrigerate at 2–8 °C, protected from light
Supplies Needed
For an 8–16 week protocol:
| Duration | Vials | Syringes | Bacteriostatic Water | Alcohol Swabs |
|---|---|---|---|---|
| 8 weeks | 4 | 56 | 12 mL (2×10 mL bottles) | 112 (2×100-count) |
| 12 weeks | 7 | 84 | 21 mL (3×10 mL bottles) | 168 (2×100-count) |
| 16 weeks | 10 | 112 | 30 mL (3×10 mL bottles) | 224 (3×100-count) |
How It Works
Ultra-short peptides can enter cells via peptide transporters and act as epigenetic modulators of gene expression, influencing protein synthesis and cellular stress responses. Hepatoprotective peptide literature indicates these compounds may mitigate liver injury markers in models, though clinical translation varies by molecule.
Storage Instructions
Lyophilized: Store at −20 °C in dry, dark conditions; minimize moisture exposure.
Reconstituted: Refrigerate at 2–8 °C; protect from light; avoid repeated freeze-thaw cycles.
Note: Allow vials to reach room temperature before opening to reduce condensation uptake.
Injection Technique
– Clean vial stopper and skin with alcohol; allow to dry
– Pinch skinfold; insert needle at 45–90° into subcutaneous tissue
– Do not aspirate; inject slowly and steadily
– Rotate sites systematically (abdomen, thighs, upper arms)
Potential Benefits
Research signals indicate peptides may modulate cellular stress/antioxidant pathways and reduce hepatocellular injury markers in preclinical models. Subcutaneous delivery enables slow, sustained absorption typical of peptide biologics.
Potential Side Effects
– Doses escalated too quickly may cause insomnia, anxiety, or fatigue
– Mild injection-site reactions (redness, itching, soreness) may occur with rotation needed
– Some individuals report transient headache or flushing (typically dose-dependent)
– Doses exceeding ~200–300 mg/day should be reserved for supervised therapeutic use
Lifestyle Factors
– Pair with balanced, protein-forward diet tailored to energy needs
– Combine resistance training and aerobic activity for metabolic support
– Prioritize sleep and stress management
Important Notes
– Use new sterile insulin syringes; dispose in sharps container
– Rotate injection sites to reduce local irritation and tissue changes
– Document daily dose and site rotation for consistency
– This guide is for therapeutic educational purposes only and does not constitute medical advice
—
Disclaimer: This content is intended for therapeutic educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult a qualified healthcare professional before beginning any research protocol.